Robert Matsuk Archives - CDR – Chain Drug Review

Glenmark opens U.S. manufacturing plant in Monroe, N.C.

October 31, 2018 by Chain Drug Review Chris Platé, executive director of Monroe-Union County Economic Developme, Glenmark Pharmaceuticals, Robert Matsuk, U.S. Senator Richard Burr Leading Headlines, Pharmacy, Supplier News

PARAMUS, N.J. – Glenmark Pharmaceuticals, a global pharmaceutical company, announced the official inauguration of its manufacturing site in Monroe, N.C. The Monroe facility will serve as the first manufacturing site for Glenmark in the United States, and the company anticipates the site will grow well beyond its current 168 employees. The Glenmark site is the

FDA approves sANDA for Glenmark Pharmaceuticals’ Monroe facility

June 18, 2018 by Chain Drug Review atovaquone and proguanil hydrochloride tablets, GlaxoSmithKline's Malarone, Glenmark Pharmaceuticals, Robert Matsuk Pharmacy, Supplier News

PARAMUS, N.J. — Glenmark Pharmaceuticals announced that the U.S. Food & Drug Administration provided its first supplemental Abbreviated New Drug Application (sANDA) approval for the company’s manufacturing facility in Monroe, N.C. The approval covers: atovaquone and proguanil hydrochloride tablets, 250 mg/100 mg and 62.5 mg/25 mg, a generic version of GlaxoSmithKline’s Malarone (atovaquone and proguanil hydrochloride)